← ZEME AI  ·  Signals  ·  Screener  ·  Ask ZEME
HPL Hoechst Pakistan Limited · Pharmaceuticals

Is HPL a Buy? HPL Smart-Money Analysis, Fair Value & Signal

ZEME verdict — Watch_Only phase
Neutral — no decisive smart-money signal yet; better setups may exist.
PriceRs 4,032.14
ZEME fair valueRs 4,430.20
Discount to fair value9.9%
Smart-money phaseWatch_Only
Confidence score0/100
RSI (14)55.1
P/E12.7
ROE—%
Dividend yield6.0%
52-week rangeRs 2,970.45 – Rs 4,808.99
SectorPharmaceuticals
Shariah-compliantYes ☪
✅ Get HPL signals free — create your ZEME account 📈 Live interactive chart & signals 💬 Ask ZEME about HPL

HPL (Hoechst Pakistan Limited) trades at Rs 4,032.14 on the Pakistan Stock Exchange, in the Watch_Only smart-money phase — neutral. ZEME's model puts fair value near Rs 4,430.20, making it about 9.9% undervalued. No decisive smart-money footprint yet — one to watch, not chase.

ZEME AI reads HPL through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.

Is HPL a buy right now?

Neutral — no decisive smart-money signal yet; better setups may exist. No decisive smart-money footprint yet — one to watch, not chase. As of 20 Jul 2026, HPL is in the Watch_Only phase with a ZEME confidence score of 0/100.

What is HPL's fair value?

ZEME estimates HPL's fair value at about Rs 4,430.20, versus a market price of Rs 4,032.14 — roughly 9.9% undervalued.

What smart-money phase is HPL in?

HPL is currently in the Watch_Only phase. No decisive smart-money footprint yet — one to watch, not chase.

More Pharmaceuticals stocks Fundamentals Dividend blue-chips ✓ Track record

Data updated 20 Jul 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.